Viveve Medical (VIVE) Competitors $0.0002 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends VIVE vs. NMRD, BRSH, UTRS, MOTS, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, and CTCXWShould you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Nemaura Medical (NMRD), Bruush Oral Care (BRSH), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and Carmell (CTCXW). These companies are all part of the "medical equipment" industry. Viveve Medical vs. Nemaura Medical Bruush Oral Care Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care Carmell Viveve Medical (NASDAQ:VIVE) and Nemaura Medical (NASDAQ:NMRD) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership. Does the MarketBeat Community prefer VIVE or NMRD? Viveve Medical received 307 more outperform votes than Nemaura Medical when rated by MarketBeat users. Likewise, 73.70% of users gave Viveve Medical an outperform vote while only 57.14% of users gave Nemaura Medical an outperform vote. CompanyUnderperformOutperformViveve MedicalOutperform Votes31173.70% Underperform Votes11126.30% Nemaura MedicalOutperform Votes457.14% Underperform Votes342.86% Which has more volatility & risk, VIVE or NMRD? Viveve Medical has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500. Does the media prefer VIVE or NMRD? In the previous week, Nemaura Medical had 1 more articles in the media than Viveve Medical. MarketBeat recorded 1 mentions for Nemaura Medical and 0 mentions for Viveve Medical. Viveve Medical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Viveve Medical Neutral Nemaura Medical Neutral Is VIVE or NMRD more profitable? Company Net Margins Return on Equity Return on Assets Viveve MedicalN/A N/A N/A Nemaura Medical N/A N/A N/A Which has preferable earnings and valuation, VIVE or NMRD? Viveve Medical has higher earnings, but lower revenue than Nemaura Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViveve MedicalN/AN/AN/AN/AN/ANemaura Medical$80K0.00-$14.14M-$0.39N/A Do insiders & institutionals hold more shares of VIVE or NMRD? 4.4% of Nemaura Medical shares are owned by institutional investors. 5.7% of Viveve Medical shares are owned by company insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryNemaura Medical beats Viveve Medical on 4 of the 7 factors compared between the two stocks. Get Viveve Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVE vs. The Competition Export to ExcelMetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$3.54B$5.39B$9.13BDividend YieldN/A1.66%5.37%4.00%P/E RatioN/A18.4188.8317.53Price / SalesN/A59.091,282.2680.28Price / CashN/A39.0936.6032.90Price / BookN/A3.974.964.69Net IncomeN/A$94.49M$117.89M$224.57M7 Day PerformanceN/A6.53%2.75%3.33%1 Month PerformanceN/A5.65%3.63%5.33%1 Year PerformanceN/A3.56%27.27%22.97% Viveve Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVEViveve MedicalN/A$0.00flatN/AN/A$0.00N/A0.0070NMRDNemaura MedicalN/AN/AN/AN/A$4,000.00$3,017.000.0040BRSHBruush Oral CareN/A$0.00flatN/A-98.7%$1,000.00$2.92M0.0011UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160MOTSMotus GIN/AN/AN/A-100.0%$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.30+19.5%N/A+9.8%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.06+17.0%N/AN/A$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.05flatN/AN/A$0.00N/A0.00N/AGap UpHigh Trading VolumeBBLGWBone BiologicsN/A$54.50+4.7%N/A+993.1%$0.00N/A0.002Positive NewsGap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011News CoverageCTCXWCarmellN/A$0.05+22.9%N/AN/A$0.00$32,839.000.0014Positive NewsGap Up Related Companies and Tools Related Companies Nemaura Medical Competitors Bruush Oral Care Competitors Minerva Surgical Competitors Motus GI Competitors Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors Bruush Oral Care Competitors Carmell Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VIVE) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.